Literature DB >> 14725126

Tenofovir: a nucleotide analogue reverse-transcriptase inhibitor for treatment of HIV infection.

Robert DeChristoforo1, Scott R Penzak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14725126     DOI： 10.1093/ajhp/61.1.86

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN： 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  3 in total

1.  Associations of antiretroviral drug use and HIV-specific risk factors with carotid intima-media thickness.

Authors:  Joseph A C Delaney; Rebecca Scherzer; Mary L Biggs; Michael G Shliplak; Joseph F Polak; Judith S Currier; Richard A Kronmal; Christine Wanke; Peter Bacchetti; Daniel O'leary; Phyllis C Tien; Carl Grunfeld
Journal:  AIDS       Date:  2010-09-10       Impact factor: 4.177

2.  In vitro evaluation of the metabolic enzymes and drug interaction potential of triapine.

Authors:  Anand Joshi; Brian F Kiesel; Nupur Chaphekar; Reyna Jones; Jianxia Guo; Charles A Kunos; Sarah Taylor; Edward Chu; Raman Venkataramanan; Jan H Beumer
Journal:  Cancer Chemother Pharmacol       Date:  2020-09-28       Impact factor: 3.333

3.  Acute Kidney Injury, Risk Factors, and Prognosis in Hospitalized HIV-Infected Adults in South Africa, Compared by Tenofovir Exposure.

Authors:  Faheem Seedat; Neil Martinson; Katlego Motlhaoleng; Pattamukkil Abraham; Dalu Mancama; Saraladevi Naicker; Ebrahim Variava
Journal:  AIDS Res Hum Retroviruses       Date:  2016-09-07       Impact factor: 2.205
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.